Menstrual cycle phase and single tablet antiretroviral medication adherence in women with HIV

References

• Allen, S. S., Allen, A. M., & Pomerleau, C. S. (2009). Influence of phase-related variability in premenstrual symptomatology, mood, smoking withdrawal, and smoking behavior during ad libitum smoking, on smoking cessation outcome. Addictive Behaviors, 34(1), 107–111. doi: 10.1016/j.addbeh.2008.08.009
   PubMed Web of Science ®Google Scholar
• Arnsten, J., Demas, P., Farzadegan, H., Grant, R., Gourevitch, M., Chang, C.-J., … Schoenbaum, E. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417–1423. doi: 10.1086/323201
   PubMed Web of Science ®Google Scholar
• Bacon, M. C., von Wyl, V., Alden, C., Sharp, G., Robison, E., Hessol, N., … Young, M. A. (2005). The Women's Interagency HIV Study: An observational cohort brings clinical sciences to the bench. Clinical Diagnostic Laboratory Immunology, 12(9), 1013–1019.
   PubMedGoogle Scholar
• Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., & Moss, A. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15(9), 1181–1183. doi: 10.1097/00002030-200106150-00015
   PubMed Web of Science ®Google Scholar
• Bangsberg, D. R., Ragland, K., Monk, A., & Deeks, S. G. (2010). A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS, 24(18), 2835–2840. doi: 10.1097/QAD.0b013e328340a209
   PubMed Web of Science ®Google Scholar
• Barkan, S. E., Melnick, S. L., Preston-Martin, S., Weber, K., Kalish, L. A., Miotti, P., … Feldman, J. (1998). The women's interagency HIV study. WIHS collaborative study group. Epidemiology, 9(2), 117–125. doi: 10.1097/00001648-199803000-00004
   PubMed Web of Science ®Google Scholar
• Cook, J. A., Cohen, M. H., Burke, J., Grey, D., Anastos, K., Kirstein, L., … Young, M. (2002). Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. JAIDS Journal of Acquired Immune Deficiency Syndromes, 30(4), 401–409. doi: 10.1097/00042560-200208010-00005
   PubMed Web of Science ®Google Scholar
• Cook, J. A., Grey, D., Burke, J., Cohen, M. H., Gurtman, A. C., Richardson, J. L., … Hessol, N. A. (2004). Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. American Journal of Public Health, 94(7), 1133–1140. doi: 10.2105/AJPH.94.7.1133
   PubMed Web of Science ®Google Scholar
• Fumaz, C. R., Munoz-Moreno, J. A., Ferrer, M. J., Negredo, E., Perez-Alvarez, N., Tarrats, A., & Clotet, B. (2009). Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders. AIDS Patient Care STDS, 23(6), 463–468. doi: 10.1089/apc.2009.0016
   PubMed Web of Science ®Google Scholar
• Gandhi, M., Ameli, N., Bacchetti, P., Anastos, K., Gange, S. J., Minkoff, H., … Greenblatt, R. M. (2011). Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clinical Infectious Diseases, 52(10), 1267–1275. doi: 10.1093/cid/cir131
   PubMed Web of Science ®Google Scholar
• Gandhi, M., Ameli, N., Bacchetti, P., Gange, S. J., Anastos, K., Levine, A., … Greenblatt, R. M. (2009). Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS, 23(4), 471–478. doi: 10.1097/QAD.0b013e328325a4a9
   PubMed Web of Science ®Google Scholar
• Gandhi, M., Benet, L. Z., Bacchetti, P., Kalinowski, A., Anastos, K., Wolfe, A. R., … Greenblatt, R. M. (2009). Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50(5), 482–491. doi: 10.1097/QAI.0b013e31819c3376
   PubMed Web of Science ®Google Scholar
• Gifford, A., Borman, J., Shively, M., Wright, B., Richman, D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. JAIDS Journal of Acquired Immune Deficiency Syndromes, 23, 386–395. doi: 10.1097/00126334-200004150-00005
   PubMed Web of Science ®Google Scholar
• Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J., … Wenger, N. S. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17(10), 756–765. doi: 10.1046/j.1525-1497.2002.11214.x
   PubMed Web of Science ®Google Scholar
• Hanna, D. B., Hessol, N. A., Golub, E. T., Cocohoba, J. M., Cohen, M. H., Levine, A. M., … Kaplan, R. C. (2014). Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. JAIDS Journal of Acquired Immune Deficiency Syndromes, 65(5), 587–596. doi: 10.1097/QAI.0000000000000082
   PubMed Web of Science ®Google Scholar
• Haubrich, R., Little, S., Currier, J., Forthal, D., Kemper, C., Beall, G., … McCutchan, J. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS, 13, 1099–1107. doi: 10.1097/00002030-199906180-00014
   PubMed Web of Science ®Google Scholar
• Hessol, N. A., Schneider, M., Greenblatt, R. M., Bacon, M., Barranday, Y., Holman, S., … Weber, K. (2001). Retention of women enrolled in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy. American Journal of Epidemiology, 154(6), 563–573. doi: 10.1093/aje/154.6.563
   PubMed Web of Science ®Google Scholar
• Hessol, N. A., Weber, K. M., Holman, S., Robison, E., Goparaju, L., Alden, C. B., … Ameli, N. (2009). Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States. Journal of Womens Health (Larchmt), 18(10), 1627–1637. doi: 10.1089/jwh.2008.1337
   PubMed Web of Science ®Google Scholar
• Kalichman, S. C., Catz, S., & Ramachandran, B. (1999). Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. Journal of National Medical Association, 91(8), 439–446.
   PubMed Web of Science ®Google Scholar
• Kobin, A. B., & Sheth, N. U. (2011). Levels of adherence required for virologic suppression among newer antiretroviral medications. Annals of Pharmacotherapy, 45(3), 372–379. doi: 10.1345/aph.1P587
   PubMed Web of Science ®Google Scholar
• Lande, R. G., & Karamchandani, V. (2002). Chronic mental illness and the menstrual cycle. Journal of American Osteopathic Association, 102(12), 655–659.
   PubMedGoogle Scholar
• Leserman, J., Ironson, G., O'Cleirigh, C., Fordiani, J. M., & Balbin, E. (2008). Stressful life events and adherence in HIV. AIDS Patient Care STDS, 22(5), 403–411. doi: 10.1089/apc.2007.0175
   PubMed Web of Science ®Google Scholar
• Mann, B., Milloy, M. J., Kerr, T., Zhang, R., Montaner, J., & Wood, E. (2012). Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users. HIV Medicine, 13(10), 596–601. doi: 10.1111/j.1468-1293.2012.01021.x
   PubMed Web of Science ®Google Scholar
• Mellins, C. A., Chu, C., Malee, K., Allison, S., Smith, R., Harris, L., … Larussa, P. (2008). Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care, 20(8), 958–968. doi: 10.1080/09540120701767208
   PubMed Web of Science ®Google Scholar
• Nachega, J. B., Mugavero, M. J., Zeier, M., Vitoria, M., & Gallant, J. E. (2011). Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs. Patient Preference and Adherence, 5, 357–367. doi: 10.2147/PPA.S22771
   PubMed Web of Science ®Google Scholar
• Oertelt-Prigione, S. (2012). Immunology and the menstrual cycle. Autoimmunity Reviews, 11(6–7), A486–A492. doi: 10.1016/j.autrev.2011.11.023
   Google Scholar
• Patel, P. N., & Grimes, R. M. (2006). Symptom exacerbation and adherence to antiretroviral therapy during the menstrual cycle: A pilot study. Infectious Diseases in Obstetrics and Gynecology, 2006, 1–4. doi: 10.1155/IDOG/2006/14869
   Google Scholar
• Puskas, C. M., Forrest, J. I., Parashar, S., Salters, K. A., Cescon, A. M., Kaida, A., … Hogg, R. S. (2011). Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Current HIV/AIDS Reports, 8(4), 277–287. doi: 10.1007/s11904-011-0098-0
   PubMedGoogle Scholar
• Rapkin, A. J., & Akopians, A. L. (2012). Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder. Menopause International, 18(2), 52–59.
   PubMedGoogle Scholar
• SAS Institute Inc (Ed.). (2010). SAS/STAT User's Guide, Version 9.3. Cary, North Carolina: SAS Institute Inc.
   Google Scholar
• Symonds, C. S., Gallagher, P., Thompson, J. M., & Young, A. H. (2004). Effects of the menstrual cycle on mood, neurocognitive and neuroendocrine function in healthy premenopausal women. Psychological Medicine, 34(1), 93–102. doi: 10.1017/S0033291703008535
   PubMed Web of Science ®Google Scholar
• Tyer-Viola, L. A., Corless, I. B., Webel, A., Reid, P., Sullivan, K. M., & Nichols, P. (2014). Predictors of medication adherence among HIV-positive women in North America. Journal of Obstetric, Gynecologic, & Neonatal Nursing, 43(2), 168–178. doi: 10.1111/1552-6909.12288
   PubMed Web of Science ®Google Scholar
• Willig, J. H., Abroms, S., Westfall, A. O., Routman, J., Adusumilli, S., Varshney, M., … Mugavero, M. J. (2008). Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy. AIDS, 22(15), 1951–1960. doi: 10.1097/QAD.0b013e32830efd79
   PubMed Web of Science ®Google Scholar
• Wood, S. A., Tobias, C., & McCree, J. (2004). Medication adherence for HIV positive women caring for children: In their own words. AIDS Care, 16(7), 909–913. doi: 10.1080/09540120412331290158
   PubMed Web of Science ®Google Scholar
• Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E. Jr., Brysk, L. T., Hardy, W. D., … Richman, D. D. (1991). A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Medical Care, 29(8), 786–798. doi: 10.1097/00005650-199108000-00011
   PubMed Web of Science ®Google Scholar